Lee HY, Kim SJ, Kim K, Ko YH, Kim WS. Bone involvement in patients with stage IV diffuse large B-cell lymphoma: does it have a prognostic value? Leuk Lymphoma. 2012;53(1):173-5.Lee, H.Y. , Kim, S.J. , Kim, K. , Ko, Y.H. & Kim, W.S. ( 2012 ) Bone involvement ...
Stage IV advanced diffuse large B-cell lymphoma in human immunodeficiency virus infection with achieving cure by using highly active antiretroviral therapy ... DH Lim,JY Rhee,KW Park - 《International Journal of Std & Aids》 被引量: 0发表: 2017年 Cutaneous anaplastic T‐cell lymphoma in a pat...
Pathologic quiz case: multiple pulmonary nodules in a patient with stage IV, diffuse large B-cell lymphoma. 40-year-old woman presented with fever, pleuritic chest pain, shortness of breath, and cough. She had a history of diffuse large B-cell lymphoma (stage IV)... A Omeroglu,K Sizi...
aRole of radiotherapy in patients with early-stage diffuse large B-cell lymphoma of Waldeyer's ring in remission after anthracycline-containing chemotherapy. 放射疗法的角色在有Waldeyer的圆环及早阶段散开大B细胞淋巴瘤的病人释免在anthracycline包含的化疗以后。[translate]...
Relapse in stage I(E) diffuse large B‐cell lymphomadoi:10.1002/hon.2487CNSdiffuselargeB‐celllymphomalimitedstageMYCrelapsesurvivalDespite a general favourable outcome in limited stage diffuse large B‐cell lymphoma (DLBCL), relapses occur in about 10 to 20% of patients. Prognostic models only ...
(2011) The important role of radiation therapy in early-stage diffuse large B-cell lymphoma: time to review the evidence once again. Expert Review of Anticancer Therapy 11 , 1367-1378 /Bindra, R. S., & Yahalom, J. (2011). The important role of radiation therapy in early-stage diffuse ...
Between 1975 and 1979, 81 consecutive patients with clinical Stage III or IV diffuse large cell lymphoma were randomized to prospectively receive the epipodophyllotoxin VP-16-213 as a single agent (Group 1: n = 25), or an equivalent quantity of the same drug combined with either cyclophosphamid...
Therapeutic options for limited-stage diffuse large B cell lymphoma (DLBCL) include short-course R-CHOP +/- IFRT and full-course R-CHOP +/- IFRT. In the rituximab-era, few randomized prospective studies exist to compare these treatment approaches in limited-stage DLBCL. In this retrospective ...
“The standard of care for diffuse large B-cell lymphoma has been R-CHOP for more than 30 years, and approximately 60% of patients are cured with R-CHOP,” Laura J. Zitella, MS, RN, ACNP-BC, AOCN, explained in an interview with Oncology Nursing News. “If the disease relapses, the...
Long-term observation has identified a pattern of continuing relapse in limited stage diffuse large B-cell lymphoma (DLBCL) treated by three cycles of R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone) plus involved-field irradiation. We retrospectively analysed 190 untreated patie...